The shares of Infant Bacterial Therapeutics AB (publ) have been admitted to trading on the main market of Nasdaq Stockholm (Mid Cap).
Vinge advised IBT.
The Vinge team included Erik Sjöman, Christian Lindhé and Astrid Karlsson..